Thorac Cardiovasc Surg 2021; 69(06): 548-550
DOI: 10.1055/s-0041-1724037
Short Communication

ECLS for Life-Threatening Complications in Mesothelioma Surgery: Is It Worthwhile?

1   Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Thoracic Surgery Unit, Padova University Hospital, Padova, Italy
,
Andrea Dell'Amore
1   Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Thoracic Surgery Unit, Padova University Hospital, Padova, Italy
,
Pia Ferrigno
1   Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Thoracic Surgery Unit, Padova University Hospital, Padova, Italy
,
Nicolo' Sella
2   Department of Medicine – DIMED, Padova University Hospital, Padova, Italy
,
Paolo Navalesi
2   Department of Medicine – DIMED, Padova University Hospital, Padova, Italy
3   Institute of Anesthesia and Intensive Care, Padova University Hospital, Padova, Italy
,
Federico Rea
1   Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Thoracic Surgery Unit, Padova University Hospital, Padova, Italy
› Author Affiliations

Abstract

Extracorporeal life support (ECLS) is an effective method for bridging patients to recovery in cases of respiratory and/or cardiac failure that are potentially reversible and unresponsive to conventional management. Nevertheless, there have been only few reports about the use of ECLS in oncological patients with complications due to their neoplasm or its treatment. We report the use of veno-arterial extracorporeal membrane oxygenation in three cases of severe perioperative complications following surgery for mesothelioma after induction chemotherapy at our Institution.



Publication History

Received: 27 October 2020

Accepted: 29 December 2020

Article published online:
18 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Extracorporeal Life Support Organization. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support, Version 1.4, August 2017 Ann Arbor, MI, USA
  • 2 Marulli G, Faccioli E, Bellini A, Mammana M, Rea F. Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma. Expert Rev Respir Med 2017; 11 (08) 649-660
  • 3 Burt BM, Cameron RB, Mollberg NM. et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg 2014; 148 (01) 30-35
  • 4 Faccioli E, Bellini A, Mammana M, Monaci N, Schiavon M, Rea F. Extrapleural pneumonectomies for pleural mesothelioma. Expert Rev Respir Med 2020; 14 (01) 67-79
  • 5 Reeb J, Olland A, Massard G, Falcoz PE. Extracorporeal life support in thoracic surgery. Eur J Cardiothorac Surg 2018; 53 (03) 489-494
  • 6 Tathineni P, Pandya M, Chaar B. The utility of ECMO in patients with hematologic malignancies: a literature review. Cureus 2020; 12: e9118
  • 7 Dünser M, Hasibeder W, Rieger M, Mayr AJ. Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids. Ann Thorac Surg 2004; 78 (01) 335-337
  • 8 Fica M, Suarez F, Aparicio R, Suarez C. Single site venovenous ECMO as an alternative to invasive ventilation in post-pneumonectomy fistula with acute respiratory failure. Eur J Cardiothorac Surg 2012; 41: 950-952
  • 9 Hadem J, Schroder F, Winkler T. et al. One day from dyspnea to death – unsuccessful application of ECMO in toxoplasma myocarditis following bone marrow transplantation. Clin Res Cardiol 2006; 95: 477-481
  • 10 Gow KW, Lao OB, Leong T, Fortenberry JD. Extracorporeal life support for adults with malignancy and respiratory or cardiac failure: The Extracorporeal Life Support experience. Am J Surg 2010; 199 (05) 669-675
  • 11 Lindén V, Karlén J, Olsson M. et al. Successful extracorporeal membrane oxygenation in four children with malignant disease and severe Pneumocystis carinii pneumonia. Med Pediatr Oncol 1999; 32 (01) 25-31
  • 12 Gow KW, Heiss KF, Wulkan ML. et al. Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: the extracorporeal life support experience. Crit Care Med 2009; 37 (04) 1308-1316